Psychological benefits of prostate cancer screening: The role of reassurance

Scott B. Cantor, Robert J. Volk, Alvah R. Cass, Jawaria Gilani, Stephen J. Spann

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objectives: The role of reassurance in decision-making about screening for health problems is largely unknown. We examined the reassurance value of prostate cancer screening in primary care patients. Setting and participants: One hundred and sixty eight men, aged 45-70 years, who had no history of prostate cancer, from three family medicine practices in southeast Texas. Methods: A hypothetical scenario was developed where men were asked to assume they did not have prostate cancer, and then to rank three predefined screening states with regard to reassurance value: (A) unknown (no screening), (B) normal by screening [a prostate-specific antigen (PSA) test and a digital rectal examination (DRE)] and (C) normal by biopsy (abnormal PSA test and DRE results but a negative ultrasound-guided prostate biopsy). Results: Most of the men (96.8%) associated some reassurance value with screening, considering health state A to be the worst possible health state. Results from a multivariate analysis showed that preference for screening state C was associated with a family history of prostate cancer and perceived greater risk for prostate cancer compared with other men. Conclusion: These findings suggest that prostate cancer screening may have some reassurance value for men, and that increased risk status may explain why some men prefer the added reassurance afforded by screening.

Original languageEnglish (US)
Pages (from-to)104-113
Number of pages10
JournalHealth Expectations
Volume5
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Early Detection of Cancer
Prostatic Neoplasms
Psychology
Digital Rectal Examination
Prostate-Specific Antigen
Health
Biopsy
Family Practice
Prostate
Primary Health Care
Decision Making
Multivariate Analysis
Medicine

Keywords

  • Medical decision-making
  • Prostate cancer
  • Psychology
  • Quality of life
  • Screening

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Psychological benefits of prostate cancer screening : The role of reassurance. / Cantor, Scott B.; Volk, Robert J.; Cass, Alvah R.; Gilani, Jawaria; Spann, Stephen J.

In: Health Expectations, Vol. 5, No. 2, 2002, p. 104-113.

Research output: Contribution to journalArticle

Cantor, Scott B. ; Volk, Robert J. ; Cass, Alvah R. ; Gilani, Jawaria ; Spann, Stephen J. / Psychological benefits of prostate cancer screening : The role of reassurance. In: Health Expectations. 2002 ; Vol. 5, No. 2. pp. 104-113.
@article{9f7fc88c2760439b8482e19ca890c73e,
title = "Psychological benefits of prostate cancer screening: The role of reassurance",
abstract = "Objectives: The role of reassurance in decision-making about screening for health problems is largely unknown. We examined the reassurance value of prostate cancer screening in primary care patients. Setting and participants: One hundred and sixty eight men, aged 45-70 years, who had no history of prostate cancer, from three family medicine practices in southeast Texas. Methods: A hypothetical scenario was developed where men were asked to assume they did not have prostate cancer, and then to rank three predefined screening states with regard to reassurance value: (A) unknown (no screening), (B) normal by screening [a prostate-specific antigen (PSA) test and a digital rectal examination (DRE)] and (C) normal by biopsy (abnormal PSA test and DRE results but a negative ultrasound-guided prostate biopsy). Results: Most of the men (96.8{\%}) associated some reassurance value with screening, considering health state A to be the worst possible health state. Results from a multivariate analysis showed that preference for screening state C was associated with a family history of prostate cancer and perceived greater risk for prostate cancer compared with other men. Conclusion: These findings suggest that prostate cancer screening may have some reassurance value for men, and that increased risk status may explain why some men prefer the added reassurance afforded by screening.",
keywords = "Medical decision-making, Prostate cancer, Psychology, Quality of life, Screening",
author = "Cantor, {Scott B.} and Volk, {Robert J.} and Cass, {Alvah R.} and Jawaria Gilani and Spann, {Stephen J.}",
year = "2002",
doi = "10.1046/j.1369-6513.2002.00166.x",
language = "English (US)",
volume = "5",
pages = "104--113",
journal = "Health Expectations",
issn = "1369-6513",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Psychological benefits of prostate cancer screening

T2 - The role of reassurance

AU - Cantor, Scott B.

AU - Volk, Robert J.

AU - Cass, Alvah R.

AU - Gilani, Jawaria

AU - Spann, Stephen J.

PY - 2002

Y1 - 2002

N2 - Objectives: The role of reassurance in decision-making about screening for health problems is largely unknown. We examined the reassurance value of prostate cancer screening in primary care patients. Setting and participants: One hundred and sixty eight men, aged 45-70 years, who had no history of prostate cancer, from three family medicine practices in southeast Texas. Methods: A hypothetical scenario was developed where men were asked to assume they did not have prostate cancer, and then to rank three predefined screening states with regard to reassurance value: (A) unknown (no screening), (B) normal by screening [a prostate-specific antigen (PSA) test and a digital rectal examination (DRE)] and (C) normal by biopsy (abnormal PSA test and DRE results but a negative ultrasound-guided prostate biopsy). Results: Most of the men (96.8%) associated some reassurance value with screening, considering health state A to be the worst possible health state. Results from a multivariate analysis showed that preference for screening state C was associated with a family history of prostate cancer and perceived greater risk for prostate cancer compared with other men. Conclusion: These findings suggest that prostate cancer screening may have some reassurance value for men, and that increased risk status may explain why some men prefer the added reassurance afforded by screening.

AB - Objectives: The role of reassurance in decision-making about screening for health problems is largely unknown. We examined the reassurance value of prostate cancer screening in primary care patients. Setting and participants: One hundred and sixty eight men, aged 45-70 years, who had no history of prostate cancer, from three family medicine practices in southeast Texas. Methods: A hypothetical scenario was developed where men were asked to assume they did not have prostate cancer, and then to rank three predefined screening states with regard to reassurance value: (A) unknown (no screening), (B) normal by screening [a prostate-specific antigen (PSA) test and a digital rectal examination (DRE)] and (C) normal by biopsy (abnormal PSA test and DRE results but a negative ultrasound-guided prostate biopsy). Results: Most of the men (96.8%) associated some reassurance value with screening, considering health state A to be the worst possible health state. Results from a multivariate analysis showed that preference for screening state C was associated with a family history of prostate cancer and perceived greater risk for prostate cancer compared with other men. Conclusion: These findings suggest that prostate cancer screening may have some reassurance value for men, and that increased risk status may explain why some men prefer the added reassurance afforded by screening.

KW - Medical decision-making

KW - Prostate cancer

KW - Psychology

KW - Quality of life

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=0036273911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036273911&partnerID=8YFLogxK

U2 - 10.1046/j.1369-6513.2002.00166.x

DO - 10.1046/j.1369-6513.2002.00166.x

M3 - Article

C2 - 12031051

AN - SCOPUS:0036273911

VL - 5

SP - 104

EP - 113

JO - Health Expectations

JF - Health Expectations

SN - 1369-6513

IS - 2

ER -